BDSX
BIODESIX INC
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$29.20
+1.35%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$28.95
From 52W high−4.58%
Volume100849.00
Market cap$308.09M
P/E (TTM)—
P/S (TTM)3.0x
Div yield—
Key dataSep 18, 2026
Open
$28.95
From 52W high
−4.58%
Volume
100849.00
Market cap
$308.09M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−24.5x
P/E (TTM)
—
RSI (14)
62.5
MomentumView details →
1D Return
+1.35%
YTD Return
+330.44%
SummaryUpdated Jun 1, 2026
Biodesix, Inc. (NASDAQ:BDSX) is a data-driven diagnostic solutions company founded in 2005 and headquartered in Boulder, Colorado. Originally incorporated as Elston Technologies, Inc., the company went public in October 2020. Biodesix specializes in blood-based diagnostic tests for lung disease, particularly focusing on lung cancer risk assessment and treatment guidance. The company has evolved from a research-focused organization into a commercial-stage diagnostics company with a growing sales force and expanding test portfolio.
Similar companies
Latest newsMore news →